Bioceres Crop Solutions Corp Dossier
|
SectorMaterials IndustryFertilizers & Agricultural Chemicals Beta (adjusted)0.60 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $0.35Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $22.3M Enterprise Value $45.4M Shares Outstanding 63.5M diluted Moat Rating None Next Earnings Date12 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Bioceres Crop Solutions Corp. (BIOX) is navigating a highly distressed operational and financial transition. While its core biological ag-inputs and proprietary HB4 drought-tolerant technology platform hold long-term promise, the company is severely constrained by liquidity pressures. The foreclosure of its Pro Farm Group (PFG) assets in January 2026 triggered a massive $179 million non-cash impairment loss, leading to the classification of PFG as discontinued operations and raising substantial doubt about the company's ability to continue as a going concern. Although management is actively pursuing liability management, debt reprofiling, and cost-streamlining initiatives, near-term earnings volatility and macroeconomic headwinds in Argentina warrant a cautious 'Hold' stance until a sustainable capital structure is established. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario Refinancing efforts fail, leading to severe liquidity shortfalls or technical defaults on remaining debt. Continued weak farmer economics in Argentina and adverse weather events suppress demand for crop protection and nutrition products, while the residual debt from the Pro Farm foreclosure crystallizes at a high value, forcing further dilutive capital raises or restructuring. Base CaseCentral scenario The company successfully refinances its short-term obligations with local Argentine financial institutions and stabilizes its continuing operations. Core biologicals and Crop Nutrition (microbeaded fertilizers) drive moderate revenue recovery, while the transition to an asset-light seed model reduces capital intensity. Legal disputes with Pro Farm noteholders are settled without further material cash outflows, allowing the going concern warning to be lifted. Bull CaseUpside scenario Successful stabilization of the capital structure through debt reprofiling, combined with accelerated commercialization of HB4 drought-tolerant wheat and soy in key markets like the US and Brazil, driving high-margin growth from continuing operations. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |